NCT02482129View on ClinicalTrials.gov

Proof of Concept Study to Evaluate Safety and Efficacy of LME636 in the Treatment of Acute Anterior Uveitis

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 17, 2015

Primary Completion Date

March 21, 2016

Study Completion Date

March 21, 2016

Conditions
Acute Anterior Uveitis
Interventions
DRUG

LME636 60 mg/mL ophthalmic solution

DRUG

Dexamethasone 0.1% ophthalmic solution

DRUG

LME636 Vehicle

Inactive ingredients used for masking purposes

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY